clinical trial · NCT05027685
The "Global Paradise System" Registry
ReCor Medical, Inc.·—·recruiting·n = 3,000
HypertensionThe Paradise Ultrasound Renal Denervation System
brief summary
The GPS Registry is a multi-centre, single-arm, non-interventional (observational) registry. In addition to collecting data from patients treated as per standard clinical practice, the Registry will also regularly collect telemetric Home Blood Pressure (HBP) measurements and Patient Reported Outcome (PRO) data via a standardized quality of life questionnaire. The objective of the GPS Registry is to document the long-term safety and effectiveness of the commercially available Paradise Ultrasound Renal Denervation System when used per its labelling in patients deemed to be candidates for RDN as per physician's assessment.
started
Jan 13, 2022
primary completion
Dec 31, 2030
completion
Dec 31, 2031
last updated
Jul 7, 2023
official title
The "Global Paradise® System" Registry
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol